Work

Irradiation-induced calreticulin secretion normalizes tumor vasculature to enhance immunotherapy

Year: 2026
Type: article
Abstract: The enhanced efficacy of immune checkpoint blockade (ICB) when combined with radiotherapy (RT) depends on effective immune cell infiltration into tumors through a normalized vasculature, rather than through the typically disorganized and dysfunctional tumor blood vessels. However, the molecular factors driving RT-induced vascular remodeling remain unclear. In this study, we demonstrated that RT promotes tumor vascular normalization, enhances T cell infiltration, and improves the long-term therapeutic efficacy of anti-PD-L1 immunotherapy in murine models. Proteomic profiling of the RT-induced tumor cell secretome identified calreticulin (CRT) as a key mediator that induces genes associated with endothelial maturation in vitro. Furthermore, melanoma and lung tumors in which Calr was stably silenced failed to exhibit radiation-induced vascular normalization within the tumor microenvironment and showed diminished responsiveness to RT. Notably, CRT deficiency abrogated the robust tumor growth suppression achieved by the triple combination of RT, anti-VEGFR2, and anti-PD-L1 therapy. These findings reveal CRT as a critical regulator of RT-induced vascular remodeling and provide mechanistic insight into how RT optimizes anti-tumor immunity. This work supports the strategic integration of RT with antiangiogenic and ICB therapies to enhance therapeutic outcomes.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,590
OpenAlex ID: W7225883198
FWCI:
Cites:
Cited by:
Related to: 10